Pfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal

There hasn't been an approved Lyme disease vaccine for more than 20 years, after GSK pulled its shot due to a lack of demand.

Pfizer’s Lyme Vaccine Shows Strong Efficacy, but Misses Mark in Study

The drugmaker is seeking regulatory review for the first new shot to combat the disease in decades.

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Lyme disease is an illness caused by bacteria most commonly spread to humans from ticks. It can cause arthritis, muscle ...

Pfizer’s Lyme vaccine shows efficacy, but misses key statistical hurdle

The vaccine could represent a weapon for preventing Lyme, a bacterial infection carried by ticks that is diagnosed and ...

Pfizer to seek FDA approval for Lyme vaccine as CT report shows ticks are more abundant than ever

The annual tick report shows Lone Star ticks have established populations along Connecticut's shoreline, raising the risk of ...

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Pfizer and France's Valneva said on Monday their experimental Lyme disease vaccine showed ‌more than 70% efficacy in a ...
Fierce Biotech

Pfizer, Valneva blame low Lyme cases for phase 3 vaccine fail but still plan approval push

Pfizer and Valneva have blamed “fewer than anticipated” Lyme disease cases for the failure of their phase 3 trial to hit its ...

Pfizer working to get approval on new Lyme disease vaccine. Expert says tick activity rising in New England.

Pfizer is working to get approval on a new vaccine that could protect people against Lyme disease, but the company could see ...

Pfizer says long-awaited Lyme vaccine was effective in study

Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, though ...

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...
WWMT on MSN

Pfizer announces promising trial results for Lyme disease vaccine

An announcement from Pfizer means Lyme disease numbers could soon drop.
STAT

Pfizer’s Lyme vaccine results set up tricky regulatory path

New results on Pfizer's Lyme disease vaccine, how the Middle East conflict could strain drug supply chains, and more biotech ...